Repeated subarachnoid administrations of autologous mesenchymal stromal cells supported in autologous plasma improve quality of life in patients suffering incomplete spinal cord injury.
Vaquero J, Zurita M, Rico MA, Bonilla C, Aguayo C, Fernández C, Tapiador N, Sevilla M, Morejón C, Montilla J, Martínez F, Marín E, Bustamante S, Vázquez D, Carballido J, Rodríguez A, Martínez P, García C, Ovejero M, Fernández MV; Neurological Cell Therapy Group.
Vaquero J, et al. Among authors: montilla j.
Cytotherapy. 2017 Mar;19(3):349-359. doi: 10.1016/j.jcyt.2016.12.002. Epub 2017 Jan 6.
Cytotherapy. 2017.
PMID: 28089079
Free article.
Clinical Trial.